OpenAI Acquires Orchestra Bio to Enhance Drug Development Efficiency with AI
OpenAI has acquired Orchestra Bio, a platform designed to assist pharmaceutical teams in managing drug development processes. This acquisition aims to enhance the capabilities of OpenAI's Rosalind initiative, which focuses on life sciences research. By integrating Orchestra's technology, OpenAI inte...